期刊文献+

“智能化用药监控系统”在减少可预防药物不良事件中的作用分析 被引量:3

Effects of the "Intelligent Drug Use Monitoring System" on Decreasing Preventable Adverse Drug Events
原文传递
导出
摘要 目的:为医院减少可预防药物不良事件(ADEs)提供参考。方法:选择某院神经内科、肾脏内科为试验组,以消化内科为对照组。2008年8月1日-2009年7月31日,2组均不进行干预;2009年8月1日-2010年7月31日,在试验组中以自行研发的"智能化用药监控系统"审查处方,将审查出的禁忌证、剂量、频次等用药错误警示定期反馈给医师并进行用药教育,而对照组不进行干预。对2组研究时间段内(2008年8月1日-2010年7月31日)的各种ADEs进行监测。结果:在试验组中,干预前发现可预防ADEs48例,发生率为3.8%,而干预后发现可预防ADEs30例,发生率为1.7%;用药错误警示例数及占处方量百分比以2个月时间段计从最高的378例和2.60%下降到最低的134例和0.91%。其下降均有统计学意义,并因此而节省211662元住院费用,减少了139天住院时间。而对照组相关数据没有显著变化。另外,不可预防的ADEs试验组与对照组干预前、后均没有显著变化。结论:当处方中存在违反禁忌证或剂量、频次等错误时,能够被"智能化用药监控系统"识别,由此可降低医院可预防ADEs的发生率。 OBJECTIVE: To provide reference for reducing preventable adverse drug events (ADEs). METHODS: We selected the neurology department and nephrology department as the experiment group, and the gastroenterology department as the control group. During Aug. 1st, 2008--Jul. 31st, 2009, both groups were not intervened; During Aug. 1st, 2009-Jul. 31st, 2010, in the experimental group, the "intelligent drug use monitoring system" was adopted to examine prescriptions and returned the medication errors, such as contraindications, dose, frequency, to the doctors and gave the relative education. There were no interventions in the control group. Various ADEs of two groups were monitored during Aug. 1st, 2008--Jul. 31st, 2010. RESULTS: In the experimental group, 48 preventable ADEs were discovered, and the incidence was 3.8%. After intervention, 30 preventable ADEs were found out, and the incidence was 1.7%. Medication errors and their percentage to prescriptions were decreased from 378 cases the most and 2.60% to 134 cases and 0.91% the least during each two months. There was statistical significance. 211 662 yuan of the extra cost of hospitalization were saved, and 139 days of the length of stay were shortened. There was no significant change in the control group. There was no significant change of unpreventable ADEs in neither groups before and after intervention. CONCLUSION: When contraindications, dose and frequency errors are present in prescriptions, they can be found out by the "system", and the incidence of preventable ADEs are able to be declined.
作者 翟晓波 何志高 鲍思蔚 徐婷 方芳 ZHAI Xiao-bo;HE Zhi-gao;BAO Si-wei;FANG Fang(Dept.of Pharmacy,Shanghai Dongfang Hospital Affiliated to Tongji University,Shanghai 200030,China)
出处 《中国药房》 CAS CSCD 2012年第1期4-8,共5页 China Pharmacy
基金 上海市卫生局科研课题(2009163) 同济-国药医院管理研究基金项目(TJGY0803)
关键词 智能化用药监控系统 禁忌证 剂量 频次 可预防药物不良事件 Intelligent drug use monitoring system Contraindications Dose Frequency Preventable adverse drug events
  • 相关文献

参考文献10

二级参考文献31

  • 1陈苏宁,张三奇,唐荔,石玉.利用PASS对临床住院患者用药医嘱的监测分析[J].中国药房,2006,17(3):185-187. 被引量:12
  • 2袁进,龚丽娴,石磊,赵树进.利用PASS监控我院医嘱合理用药水平的调研与干预研究[J].药品评价,2006,3(4):293-294. 被引量:8
  • 3郭红,孙艳,陈海滨,漆学珍.利用PASS系统对肿瘤住院患者医嘱实施同步监测[J].中国药房,2007,18(14):1117-1118. 被引量:12
  • 4翟晓波,鲍思蔚,王海平,何志高.严重药物不良事件对住院时间和费用的影响分析[J].药物流行病学杂志,2007,16(3):153-156. 被引量:21
  • 5Smith K M, Jeske C S, Young B, et al. Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients[J]. Neurosurgery,2006, 58(3):426-433.
  • 6Zandieh S O, Goldmann D A, Keohane C A, et al. Risk factors in preventable adverse drug events in pediatric outpatients [J]. J Pediatr, 2008, 152(2):225-231.
  • 7Nuckols T K, Paddock S M, Bower A G, et al. Costs of intra venous adverse drug events in academic and nonacademic intensive care units[J]. Med Care,2008, 46(1):17-24.
  • 8Thomsen L A, Winterstein A G, Sφndergaard B, et al. Sys tematic review of the incidence and characteristics of preventa ble adverse drug events in ambulatory care[J]. Ann Pharma cother,2007, 41(9):1411-1426.
  • 9倪语星,韩证中.抗菌药物临床应用--从抗菌谱到临床处方[M].上海:上海科学技术出版社,2006.32-40.
  • 10Nuckols TK,Paddock SM,Bower AG.et al.Cesta of intravenotm advers drug events in academic and nonacademic intensive care units[J].Med Care,2008,46(1):17

共引文献42

同被引文献42

  • 1卜晖.临床用药统计与控制软件逻辑[J].航空航天医学杂志,2009,21(10):53-54. 被引量:1
  • 2姜峻,曾民,李刚.自动监控抗生素合理应用系统的开发与应用[J].中国药房,2007,18(4):271-273. 被引量:8
  • 3李泽辉,王晓丹,章萍,张秀立.药品不良事件与医院用药安全防范体系的构建[J].中国医院药学杂志,2007,27(5):666-668. 被引量:9
  • 4Hwang SH, Lee S, Koo HK, et al. Evaluation of a com-puter-based adverse-drug-event monitor[J].^m J Health Syst Pharm,2008,65(23) : 2 265.
  • 5Ducharaie MM,Boothby LA.Analysis of adverse drug reactions for preventability[J]. Int J Clin Pract,2007, 61 (1):157.
  • 6Linder JA, Haas JS, Iyer A, et al. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting[J]. Pharmacoepidemiol Drug Saf, 2010,19(12):1211.
  • 7Yen YH, Kuo LN, Hsu MH, et al. Evaluation of the electronic adverse drug event management system[J]. Journal of Experimental and Clinical Medicine, 2010,2 (6) :287.
  • 8Rommers MK, Zegers MH, De Clercq PA, et a/.Devel-Opment of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event[J]. Qual Saf Health Care,2010,19(6) :35.
  • 9Lisby M, Nielsen LP, Brock B, et al. How are medication errors defined7A systematic literature review of defini-tions and characteristics[J] Jnt J Qual Health Care, 2010, 22(6):507.
  • 10Johann-Liang R, Wyeth J, Chen M, ef a/.Pediatric drug surveillance and the Food and Dmg Administration ’ s adverse event reporting system: an overview of reports, 2003 一 2007[J]. Pharmacoepidemiol Drug Safy 2009, 18 (l):24.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部